These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 2086166)
1. Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Nilsson G; Lindblom P; Ohlin M; Berling R; Vernersson E Drugs Exp Clin Res; 1990; 16(6):307-14. PubMed ID: 2086166 [TBL] [Abstract][Full Text] [Related]
2. Uterine effects of N-alpha-triglycyl-(8-lysine)-vasopressin and 8-lysine-vasopressin in the first trimester of pregnancy. Laudański T; Akerlund M Contraception; 1980 Aug; 22(2):199-208. PubMed ID: 7449382 [TBL] [Abstract][Full Text] [Related]
3. The effect of triglycyl-lysine-vasopressin (terlipressin INN, Glypressin) on skin blood flow, measured with laser Doppler flowmetry, thermography and plethysmography. A dose-response study. Nilsson G; Lindblom P; Palmer B; Vernersson E; Aberg M Scand J Plast Reconstr Surg Hand Surg; 1987; 21(2):149-57. PubMed ID: 2961054 [TBL] [Abstract][Full Text] [Related]
4. The hemodynamic effects of triglycyl-lysine-vasopressin (Glypressin) in patients with parkinsonism and orthostatic hypotension. Rittig S; Arentsen J; Sørensen K; Matthiesen T; Dupont E Mov Disord; 1991; 6(1):21-8. PubMed ID: 2005918 [TBL] [Abstract][Full Text] [Related]
5. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration. Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392 [TBL] [Abstract][Full Text] [Related]
6. Conversion of triglycylvasopressin to lysine-vasopressin in man. Forsling ML; Aziz LA; Miller M; Davies R; Donovan B J Endocrinol; 1980 May; 85(2):237-44. PubMed ID: 7400711 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease. Smith WB; Dowell JA; Pratt RD Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688 [TBL] [Abstract][Full Text] [Related]
8. The influence of a single dose of vasopressin analogs on human renal potassium excretion. Nádvorníková H; Schück O Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):155-8. PubMed ID: 7076344 [TBL] [Abstract][Full Text] [Related]
9. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs. Blei AT; Groszmann RJ; Gusberg R; Conn HO Dig Dis Sci; 1980 Sep; 25(9):688-94. PubMed ID: 7418592 [TBL] [Abstract][Full Text] [Related]
10. Triglycyl-lysine-vasopressin or lysine-vasopressin in early excision of burns. An experimental study comparing the effects on blood loss, hemodynamics and renal function. Vernersson E; Palmer B; Aberg M Scand J Plast Reconstr Surg; 1984; 18(3):285-90. PubMed ID: 6528231 [TBL] [Abstract][Full Text] [Related]
11. Terlipressin: vasopressin analog and novel drug for septic shock. Pesaturo AB; Jennings HR; Voils SA Ann Pharmacother; 2006 Dec; 40(12):2170-7. PubMed ID: 17148649 [TBL] [Abstract][Full Text] [Related]
12. Effects of triglycyl-lysine-vasopressin on cardiovascular responses to orthostatic stress. Baer R; Eiken O; Balldin U Clin Physiol; 1987 Aug; 7(4):329-35. PubMed ID: 3621870 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study. Mao ZL; Stalker D; Keirns J Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403 [TBL] [Abstract][Full Text] [Related]
14. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine. Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia. Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol. Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma. Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of glipizide in healthy volunteers. Pentikäinen PJ; Neuvonen PJ; Penttilä A Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):98-107. PubMed ID: 6341263 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan at clinical and supraclinical doses. Whittem T; Pasloske KS; Heit MC; Ranasinghe MG J Vet Pharmacol Ther; 2008 Dec; 31(6):571-9. PubMed ID: 19000281 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers. Danielson BG; Salmonson T; Derendorf H; Geisser P Arzneimittelforschung; 1996 Jun; 46(6):615-21. PubMed ID: 8767353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]